Anzeige
Meldung des Tages: Gold bei 5.250 USD – Dieser 37-Mio.-€-Goldentwickler sitzt auf einem möglichen $2-Milliarden-Projekt!!

SMI

Index
WKN:  969000 ISIN:  CH0009980894
12.787,01
-0,61%
-78,621
13.03.26
Depot/Watchlist
Weiter abwärts? Short handeln - Jetzt mit Hebel 14,60: VJ7F8N
Werbung

Unternehmensmeldungen

13.03.26 - GlobeNewswire
Novartis Cosentyx® receives FDA approval for pediatric patients aged 12+ with moderate to severe hidradenitis suppurativa
Cosentyx is the only IL-17A inhibitor approved for this population, and the first differentiated mechanism in nearly a decade 1-3 HS often emerges around puberty, underscoring ...
12.03.26 - EQS
Sehr gutes Geschäftsjahr 2025
Geberit AG / Schlagwort(e): Research Update Sehr gutes Geschäftsjahr 2025 12.03.2026 / 08:05 CET/CEST
12.03.26 - EQS
Holcim expands in Colombia
Holcim Group Services Ltd / Key word(s): Mergers & Acquisitions Holcim expands in Colombia 12.03.2026 / 06:30 CET/CEST
09.03.26 - EQS
Lonza and Genetix Biotherapeutics Extend Commercial Manufacturing Agreement for ZYNTEGLO™
Lonza Group AG / Key word(s): Partnership/Agreement Lonza and Genetix Biotherapeutics Extend Commercial Manufacturing Agreement for ZYNTEGLO™ 09.03.2026 / 14:00 CET/CEST
06.03.26 - EQS
Partners Group announces credit rating from Moody's Ratings
Partners Group / Key word(s): Rating Partners Group announces credit rating from Moody's Ratings 06.03.2026 / 18:30 CET/CEST
06.03.26 - GlobeNewswire
Novartis shareholders approve all resolutions proposed by the Board of Directors at the 2026 Annual General Meeting
Shareholders approve 29th consecutive dividend increase to CHF 3.70 (+5.7%) per share for 2025, representing a 3.0% yield¹ Shareholders confirm Giovanni Caforio as Chair of ...
06.03.26 - GlobeNewswire
Aktionäre von Novartis heissen an der Generalversammlung 2026 alle Anträge des Verwaltungsrats gut
Die Aktionärinnen und Aktionäre genehmigten die 29. Dividendenerhöhung in Folge. Für 2025 wird die Dividende auf CHF 3.70 (+5,7%) je Aktie erhöht, was einer Rendite von 3,0% ...
05.03.26 - EQS
Holcim recognized as Global Top Employer for 2026
Holcim Group Services Ltd / Key word(s): Miscellaneous Holcim recognized as Global Top Employer for 2026 05.03.2026 / 07:00 CET/CEST
03.03.26 - EQS
Amrize Launches EVERtect™ High-Performance Concrete Range at CONEXPO-CON/AGG 2026
Amrize Ltd / Key word(s): Product Launch Amrize Launches EVERtect™ High-​Performance Concrete Range at CONEXPO-​CON/AGG 2026 03.03.2026 / 17:00 CET/CEST
03.03.26 - EQS
EQS-News: Logitech G Studie: E-Sport tritt in ein goldenes Zeitalter ein
EQS-News: Logitech G / Schlagwort(e): Sonstiges Logitech G Studie: E-Sport tritt in ein goldenes Zeitalter ein 03.03.2026 / 10:55 CET/CEST Für den Inhalt der Mitteilung ist der ...
27.02.26 - GlobeNewswire
Novartis successfully completes acquisition of Avidity Biosciences, strengthening late-stage neuroscience pipeline and advancing xRNA strategy
Adds Avidity’s differentiated muscle-​directed Antibody Oligonucleotide Conjugates (AOC) platform and three late-​stage programs to industry-​leading neuromuscular pipeline ...
27.02.26 - GlobeNewswire
Novartis receives positive CHMP opinion for remibrutinib in chronic spontaneous urticaria (CSU)
Remibrutinib, a highly selective oral BTKi, has potential to be first targeted therapy approved for CSU in Europe Improvements with remibrutinib observed as early as Week 1 in ...
27.02.26 - EQS
Partners Group to sell atNorth for an EV of USD 4 billion
Partners Group / Key word(s): Mergers & Acquisitions Partners Group to sell atNorth for an EV of USD 4 billion 27.02.2026 / 09:00 CET/CEST
27.02.26 - Businesswire
Changes to the UBS Board of Directors
Regulatory News:
25.02.26 - GlobeNewswire
Novartis to build new radioligand therapy site in Denton, Texas, delivering more next‑generation treatments to patients
Facility expected to be operational in 2028 in Dallas-​Fort Worth area, expanding largest RLT manufacturing network in US Site to serve patients in Southern US and add network ...
24.02.26 - Businesswire
Alcon Delivers Strong Fourth-Quarter 2025 Topline Growth as New Product Launches Accelerate Sales
Regulatory News:
24.02.26 - GlobeNewswire
New real‑world data reinforce earlier use of Pluvicto™ before chemotherapy in metastatic castration-resistant prostate cancer
In the real-​world, Pluvicto™ showed 13.5 months median PFS in chemo-naïve patients with PSMA-​positive mCRPC Real ‑ world evidence showed Pluvicto achieved longer PFS when ...
23.02.26 - GlobeNewswire
Novartis presents Rhapsido® (remibrutinib) data at AAAAI, showing potential beyond chronic spontaneous urticaria (CSU)
Analyses from REMIX-1 & -2 studies on CSU disease control and early symptom relief will be presented Phase II data evaluating safety and efficacy results of remibrutinib for ...
23.02.26 - EQS
Partners Group announces planned office in Kuwait, expanding its presence in the GCC
Partners Group / Key word(s): Miscellaneous Partners Group announces planned office in Kuwait, expanding its presence in the GCC 23.02.2026 / 07:00 CET/CEST
20.02.26 - EQS
Partners Group addresses share price falls in listed private markets sector
Partners Group / Key word(s): Statement Partners Group addresses share price falls in listed private markets sector 20.02.2026 / 13:35 CET/CEST

Newssuche

Videos

newspaper
13.03.26 -4,81%
Technical Trading: Kurzfristig Gold Long
Gold Long Typ: Turbo Open End WKN: VC5S7W Hebel: 2 Laufzeit: OpenEnd Einstieg: Market ... Mehr »